ABLV vs SURG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 16, 2026

ABLV

42.5
AI Score
VS
SURG Wins

SURG

50.1
AI Score

Investment Advisor Scores

ABLV

43score
Recommendation
HOLD

SURG

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ABLV SURG Winner
Revenue 105.20M 56.96M ABLV
Net Income 820,018 -36.07M ABLV
Net Margin 0.8% -63.3% ABLV
Operating Income -486,613 -34.14M ABLV
ROE 10.6% 235.0% SURG
ROA 2.4% -423.6% ABLV
Total Assets 34.55M 8.52M ABLV
Cash 9.01M 1.73M ABLV
Debt/Equity 0.28 -0.99 SURG
Current Ratio 1.62 0.38 ABLV
Free Cash Flow 1.17M -21.31M ABLV

Relative Price Performance (Last 90 Days)

ABLV 1M: +127.1% · 3M: +102.9% SURG 1M: -11.7% · 3M: -59.4%

Current Technical Phase

ABLV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (36.9% over 20 days), RSI 57

RSI (14): 56.9 · Price: $2.09

SURG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -22.7%), weak momentum, RSI 35

RSI (14): 35.0 · Price: $0.13

Fundamentals Snapshot

Metric ABLV SURG
Market Cap — —
Forward P/E 0.0 12.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.3% 0.4%
Gross Margin 0.1% -0.2%
Operating Margin 0.0% 0.2%
EPS -0.03 -1.50
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SURG is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.